TWD 72.7
(-0.41%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 403.04 Million TWD | 3089.17% |
2022 | 12.63 Million TWD | -30.97% |
2021 | 18.3 Million TWD | -95.56% |
2020 | 412.05 Million TWD | 2425.91% |
2019 | 16.31 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | 402.12 Million TWD | 0.0% |
2024 Q1 | 402.22 Million TWD | 0.0% |
2023 Q4 | 403.04 Million TWD | -0.21% |
2023 FY | 403.04 Million TWD | 3089.17% |
2023 Q1 | 10.82 Million TWD | 12.86% |
2023 Q3 | 403.89 Million TWD | 7622.68% |
2023 Q2 | 5.23 Million TWD | -51.7% |
2022 Q4 | 9.59 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | -459.601% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | -429.287% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | -21.97% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | 72.369% |
Orient EuroPharma Co., Ltd. | 2.2 Billion TWD | 81.704% |
Center Laboratories, Inc. | 4.42 Billion TWD | 90.9% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -106809.019% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | -24.499% |
InnoPharmax Inc. | 5.38 Million TWD | -7383.234% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | -299.725% |
Excelsior Biopharma Inc. | 300.25 Million TWD | -34.237% |
DV Biomed Co., Ltd. | 315.74 Million TWD | -27.648% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -2973.176% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -5154.165% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | 19.341% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -291963.043% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -618.995% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -867.282% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -513.886% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |